The test analyzes the levels of two proteins in the blood and has shown a link between these levels and patient outcomes. The pilot study showed that 98% of patients with low protein levels did not develop secondary breast cancer. The test could be ready for approval in two to three years.
Latest News
11:38
Minister of Defense, Ștefan Radu Oprea, calls for strengthening prevention and response capabilities amid risks in the Black Sea region
11:23
Barack Obama attacks Donald Trump’s administration and mobilizes voters for Democratic candidates in Ohio
11:20
France and the United Arab Emirates have resumed negotiations on developing a modernized version of the Rafale fighter jet
11:12
Volkswagen employees are threatening strikes from January 2027 if the automaker does not reverse its decision regarding wage agreements
11:05
Nicusor Dan warns that Russia’s war threatens Romania’s security and freedom of navigation in the Black Sea
See more news